giroctocogene fitelparvovec phase 1/2 trial
Published 3 years ago • 230 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:32:16
recent advances in gene therapy for hemophilia presented at nhf 2021
-
3:54
gener8-1 two-year analysis as presented at eahad
-
6:21
dr. barbara konkle discusses the alta study
-
19:24
genetx biotherapeutics: gtx 102 phase 1/2 clinical trial update
-
5:00
valoctocogene roxaparvovec aav gene transfer for severe hemophilia: results from phase 3 trial
-
2:21
etranacogene dezaparvovec (aav5-padua hfix variant): two year data from a phase 2b trial
-
5:49
ultrasound of the knee
-
59:09
atypical parkinsonian disorders
-
36:32
gene therapy for fviii
-
2:19
ongoing hemophilia a gene therapy trials
-
0:44
current aav hemophilia b gene therapy trials
-
3:58
follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
-
5:08
valoctocogene roxaparvovec gene transfer for severe haemophilia a on health-related quality of life
-
0:22
ultrasound guided injection of the suprapatellar pouch knee -dr peter resteghini
-
5:26
seven-year follow-up of valoctocogene roxaparvovec gene therapy for haemophilia
-
0:16
implantable cranial ultrasound sensor for post-operative monitoring of brain tumor regrowth
-
5:34
steven pipe: etranacogene dezaparvovec gene therapy for hemophilia b
-
3:57
first-in-human gene therapy study of bay 2599023 in severe hemophilia a
-
17:08
achievement of normal fviii activity following gene transfer with valoctocogene roxaparvovec…
-
5:25
efficacy and safety of etranacogene dezaparvovec: first data from the phase 3 hope-b trial
-
2:47
intravitreal eye injection